Your browser is no longer supported. Please, upgrade your browser.
Settings
ATRS Antares Pharma, Inc. daily Stock Chart
ATRS [NASD]
Antares Pharma, Inc.
Index- P/E- EPS (ttm)0.00 Insider Own1.50% Shs Outstand161.84M Perf Week-1.40%
Market Cap571.30M Forward P/E40.57 EPS next Y0.09 Insider Trans-27.94% Shs Float151.08M Perf Month-16.75%
Income-0.60M PEG- EPS next Q0.00 Inst Own43.40% Short Float3.67% Perf Quarter-20.50%
Sales104.80M P/S5.45 EPS this Y61.40% Inst Trans8.27% Short Ratio3.80 Perf Half Y6.65%
Book/sh0.27 P/B13.07 EPS next Y325.00% ROA-0.60% Target Price6.44 Perf Year9.97%
Cash/sh- P/C- EPS next 5Y- ROE-1.40% 52W Range2.60 - 5.13 Perf YTD-24.89%
Dividend- P/FCF- EPS past 5Y23.80% ROI-25.90% 52W High-31.19% Beta0.81
Dividend %- Quick Ratio2.50 Sales past 5Y25.20% Gross Margin56.10% 52W Low35.77% ATR0.16
Employees165 Current Ratio2.90 Sales Q/Q91.60% Oper. Margin-9.90% RSI (14)30.18 Volatility4.24% 4.35%
OptionableYes Debt/Eq0.91 EPS Q/Q150.40% Profit Margin-0.60% Rel Volume0.68 Prev Close3.50
ShortableYes LT Debt/Eq0.91 EarningsMar 05 BMO Payout- Avg Volume1.46M Price3.53
Recom1.50 SMA20-5.43% SMA50-16.46% SMA200-1.76% Volume983,878 Change0.86%
Oct-23-17Reiterated H.C. Wainwright Buy $5 → $3.50
Jun-23-17Initiated H.C. Wainwright Buy $5
Apr-21-17Initiated Raymond James Strong Buy
May-28-15Initiated Jefferies Buy $5
May-18-15Initiated Piper Jaffray Overweight $3.50
Aug-08-13Reiterated Ladenburg Thalmann Buy $5 → $5.75
Jun-21-13Resumed Oppenheimer Outperform $6
Jan-27-20 07:00AM  Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million GlobeNewswire
Jan-16-20 05:59AM  Is Antares Pharma, Inc.'s (NASDAQ:ATRS) CEO Paid At A Competitive Rate? Simply Wall St.
Dec-14-19 05:20PM  Here is What Hedge Funds Think About Antares Pharma Inc (NASDAQ:ATRS) Insider Monkey
Dec-10-19 07:00AM  Antares Pharma Appoints Edward Tykot Senior Vice President, Corporate Development GlobeNewswire
Dec-06-19 07:00AM  Antares Pharma Social Media Campaign for XYOSTED® Wins MarCom Platinum Award GlobeNewswire
Dec-02-19 09:49AM  An Intrinsic Calculation For Antares Pharma, Inc. (NASDAQ:ATRS) Suggests It's 43% Undervalued Simply Wall St.
Nov-27-19 05:51PM  Antares Pharma to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-20-19 07:25AM  The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data Benzinga
Nov-19-19 07:00AM  REMINDER: Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire
01:00AM  Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire
Nov-13-19 07:00AM  Antares Pharma to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire
Nov-09-19 08:03PM  Edited Transcript of ATRS earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-05-19 07:00AM  Antares Pharma Reports Third Quarter 2019 Operating and Financial Results GlobeNewswire +8.36%
Nov-01-19 11:49AM  Hedge Funds Are Selling Antares Pharma Inc (ATRS) Insider Monkey
Oct-31-19 07:00AM  Antares Pharma Announces Receipt of Final Payment From Sale of Zomajet Needle-Free Delivery System GlobeNewswire
Oct-29-19 07:00AM  Antares Pharma to Report Third Quarter 2019 Financial and Operating Results GlobeNewswire
Oct-24-19 07:00AM  Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting GlobeNewswire
Oct-17-19 06:55AM  Do Directors Own Antares Pharma, Inc. (NASDAQ:ATRS) Shares? Simply Wall St.
Sep-17-19 07:00AM  Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire
Sep-11-19 11:50AM  Does Antares Pharma (NASDAQ:ATRS) Have A Healthy Balance Sheet? Simply Wall St.
Aug-20-19 08:09AM  Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack MarketWatch
Aug-14-19 02:14PM  Edited Transcript of ATRS earnings conference call or presentation 6-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-06-19 05:23PM  Antares Pharma Inc (ATRS) Q2 2019 Earnings Call Transcript Motley Fool +10.07%
03:00PM  Loss-Making Antares Pharma, Inc. (NASDAQ:ATRS) Expected To Breakeven Simply Wall St.
07:00AM  Antares Pharma Reports Second Quarter 2019 Operating and Financial Results GlobeNewswire
Jul-30-19 07:00AM  Antares Pharma to Report Second Quarter 2019 Financial and Operating Results GlobeNewswire
Jun-27-19 07:00AM  Antares Pharma Announces Amendment to Existing Loan and Security Agreement With Hercules Capital GlobeNewswire
Jun-26-19 02:08PM  Here is What Hedge Funds Think About Antares Pharma Inc (ATRS) Insider Monkey
Jun-11-19 07:00AM  Antares Pharma to Present at the Raymond James 2019 Life Sciences and MedTech Conference GlobeNewswire
Jun-06-19 11:45AM  Have Insiders Been Selling Antares Pharma, Inc. (NASDAQ:ATRS) Shares This Year? Simply Wall St.
May-30-19 07:00AM  Antares Pharma to Present at the Jefferies 2019 Healthcare Conference GlobeNewswire
May-16-19 05:00PM  Antares Pharma to Present at the B. Riley FBR Institutional Investor Conference GlobeNewswire
May-13-19 06:14AM  Edited Transcript of ATRS earnings conference call or presentation 2-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-09-19 02:23PM  Investors Who Bought Antares Pharma (NASDAQ:ATRS) Shares Three Years Ago Are Now Up 265% Simply Wall St.
May-02-19 01:49PM  Antares Pharma Inc (ATRS) Q1 2019 Earnings Call Transcript Motley Fool +8.76%
09:01AM  Antares Pharma: 1Q Earnings Snapshot Associated Press
07:00AM  Antares Pharma Reports First Quarter 2019 Operating and Financial Results GlobeNewswire
Apr-18-19 07:00AM  Antares Pharma to Report First Quarter 2019 Financial and Operating Results GlobeNewswire
Apr-02-19 09:43AM  Why Antares Pharma, Inc.'s (NASDAQ:ATRS) CEO Pay Matters To You Simply Wall St.
Apr-01-19 07:30AM  New Research: Key Drivers of Growth for Progress Software, Antares Pharma, National Vision, NMI, Waters, and Kelly Services Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-28-19 07:30AM  Antares Pharma Announces Receipt of Orphan Drug Designation for the Treatment of Ectopic Pregnancy With Methotrexate GlobeNewswire
Mar-15-19 03:43PM  Edited Transcript of ATRS earnings conference call or presentation 28-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Mar-12-19 06:48PM  Antares Pharma Inc (ATRS) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-11-19 10:35AM  AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study Zacks
Mar-06-19 07:00AM  Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference GlobeNewswire
Mar-04-19 07:00AM  Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella GlobeNewswire
Feb-28-19 12:31PM  Antares Pharma Inc (ATRS) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:00AM  Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results GlobeNewswire
Feb-27-19 07:00AM  Antares Pharma to Present at the Raymond James & Associates 40th Annual Institutional Investors Conference GlobeNewswire
Feb-25-19 05:00PM  Antares Pharma to Report Fourth Quarter and Full Year 2018 Financial and Operating Results GlobeNewswire +10.56%
Jan-20-19 09:49AM  Antares Pharma, Inc. (NASDAQ:ATRS): Time For A Financial Health Check Simply Wall St.
Dec-13-18 10:32AM  What Kind Of Shareholder Appears On The Antares Pharma, Inc.s (NASDAQ:ATRS) Shareholder Register? Simply Wall St.
07:00AM  Antares Pharma Announces the Appointment of Peter S. Greenleaf to Companys Board of Directors GlobeNewswire
Dec-10-18 09:45AM  ATRS: Xyosted & Epi Pen Available for Sale Zacks Small Cap Research
Dec-08-18 07:50PM  Should You Buy NanoString Technologies Inc (NSTG)? Insider Monkey
Dec-05-18 05:09PM  Is Noodles & Co (NDLS) A Good Stock To Buy? Insider Monkey
Dec-03-18 08:15AM  Factors of Influence in 2018, Key Indicators and Opportunity within Antares Pharma, Encana, PPG Industries, Cato, Cimarex Energy, and Ormat Technologies New Research Emphasizes Economic Growth GlobeNewswire
Nov-29-18 07:00AM  Antares Pharma Announces the Commercial Availability of XYOSTED (Testosterone Enanthate) Injection A New Treatment for Adult Men Diagnosed With Testosterone Deficiency GlobeNewswire
Nov-28-18 08:39AM  Teva (TEVA) Launches First Generic Version of Mylan's EpiPen Zacks +5.09%
Nov-27-18 01:47PM  Teva's generic EpiPen hits the market in limited doses American City Business Journals
10:36AM  Antares Pharma Partner Teva Announces Commercial Availability of Generic Epipen® GlobeNewswire
Nov-26-18 10:45AM  ATRS: Xyosted Launch Before Year End Zacks Small Cap Research
07:30AM  Antares Pharma to Present at the 30th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-19-18 11:51AM  Edited Transcript of ATRS earnings conference call or presentation 6-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Nov-14-18 07:38AM  Healthcare Value Capital, LLC Buys Antares Pharma Inc, Sells Novelion Therapeutics Inc GuruFocus.com
Nov-12-18 08:06PM  Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Antares Pharma, Inc. (ATRS) and Encourages ATRS Investors to Contact the Firm GlobeNewswire -7.69%
Nov-09-18 06:41PM  Robbins Arroyo LLP: Antares Pharma, Inc. (ATRS) Misled Shareholders According to Class Action Business Wire
07:00AM  Antares Pharma Announces Data Presentation at the 2018 Sexual Medicine Society Scientific Annual Meeting GlobeNewswire
Nov-08-18 07:00AM  Antares Pharma to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire
Nov-06-18 07:56AM  Antares Pharma: 3Q Earnings Snapshot Associated Press
07:00AM  Antares Pharma Reports Third Quarter 2018 Operating and Financial Results GlobeNewswire
Oct-30-18 07:00AM  Antares Pharma to Report Third Quarter 2018 Financial and Operating Results GlobeNewswire
Oct-24-18 08:20AM  Detailed Research: Economic Perspectives on Kohl's, Activision Blizzard, Amerco, Cree, Antares Pharma, and Uranium Energy What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-22-18 02:23PM  Antares Pharma Incs (NASDAQ:ATRS) Path To Profitability Simply Wall St.
Oct-02-18 03:43PM  FDA approves injectable testosterone drug patients can administer by themselves at home American City Business Journals +15.64%
12:52PM  Here's Why Antares Pharma Jumped Higher Today Motley Fool
Oct-01-18 07:53AM  Antares Pharma's testosterone drug gets FDA approval Reuters
07:07AM  Antares Pharma's testosterone drug gets FDA approval Reuters
07:00AM  Antares Receives FDA Approval of Xyosted (Testosterone Enanthate) Injection for Testosterone Replacement Therapy in Adult Males GlobeNewswire
Sep-25-18 07:00AM  Antares Pharma to Present at the Ladenburg Thalmann 2018 Healthcare Conference GlobeNewswire
Sep-07-18 10:28AM  Antares Pharma Incs (NASDAQ:ATRS) Earnings Dropped -9.2%, Did Its Industry Show Weakness Too? Simply Wall St.
Aug-31-18 07:40AM  Report: Developing Opportunities within Anthera Pharmaceuticals, NRG Energy, Antares Pharma, El Pollo Loco, Paychex, and Cinedigm Future Expectations, Projections Moving into 2018 GlobeNewswire
Aug-30-18 07:00AM  Antares Pharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference GlobeNewswire
Aug-27-18 09:15AM  ATRS: Epinephrine Pen Ready to Go Zacks Small Cap Research
Aug-19-18 11:50PM  Edited Transcript of ATRS earnings conference call or presentation 7-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-17-18 12:31PM  Why the FDA's generic EpiPen approval is a big win for a N.J. company American City Business Journals
08:00AM  Todays Research Reports on Stocks to Watch: Antares Pharma and Adamis Pharmaceuticals ACCESSWIRE
Aug-16-18 04:54PM  Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector GlobeNewswire
Aug-15-18 08:25PM  Key FDA Decisions Could Power These 3 Biopharma Stocks SmarterAnalyst
Aug-14-18 08:00AM  Todays Research Reports on Stocks to Watch: Xenetic Biosciences and Antares Pharma ACCESSWIRE
Aug-13-18 04:35PM  Why Nielsen Holdings, Diebold Nixdorf, and Antares Pharma Jumped Today Motley Fool +10.54%
Aug-07-18 04:00PM  Robbins Arroyo LLP: Antares Pharma, Inc. (ATRS) Misled Shareholders According to a Class Action Business Wire
07:35AM  Antares Pharma: 2Q Earnings Snapshot Associated Press
07:00AM  Antares Pharma Reports Second Quarter 2018 Operating and Financial Results GlobeNewswire
06:30AM  Antares Pharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 04:30PM  Antares Pharma Appoints Dr. James Tursi Executive Vice President, Head of Research & Development, Chief Medical Officer GlobeNewswire +11.15%
04:14PM  Here's Why Antares Pharma Jumped Today Motley Fool
10:20AM  Biotechnology Stocks Trending on New Developments 2018 ACCESSWIRE
08:51AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:00AM  Antares Pharma Enters Into Development Agreement With Pfizer Inc. GlobeNewswire
Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., and Pfizer Inc. The company was founded in 1978 and is headquartered in Ewing, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAMSON MARVINDirectorJan 10Option Exercise2.665614951,807Jan 14 06:07 PM
SAMSON MARVINDirectorJan 10Sale4.505625251,751Jan 14 06:07 PM
SAMSON MARVINDirectorJan 02Option Exercise2.1899,944218,141101,751Jan 06 06:06 PM
SAMSON MARVINDirectorJan 02Sale4.5999,944459,24251,751Jan 06 06:06 PM
SAMSON MARVINDirectorDec 23Option Exercise1.12150,000168,000201,751Dec 26 04:57 PM
SAMSON MARVINDirectorDec 23Sale4.71150,000706,50051,751Dec 26 04:57 PM
APPLE ROBERT FPresident & CEODec 10Option Exercise3.9658,524231,7551,964,415Dec 11 07:15 PM
APPLE ROBERT FPresident & CEODec 10Sale4.7658,524278,3581,905,891Dec 11 07:15 PM
APPLE ROBERT FPresident & CEODec 09Option Exercise2.08308,000640,3802,015,891Dec 11 07:15 PM
JACOB LEONARD SDirectorDec 09Option Exercise1.63160,000260,800377,563Dec 11 07:21 PM
GARRITY THOMAS JDirectorDec 09Option Exercise1.6380,000130,400234,186Dec 11 07:24 PM
GARRITY THOMAS JDirectorDec 09Sale4.5880,000366,472194,186Dec 11 07:24 PM
JACOB LEONARD SDirectorDec 09Sale4.63244,8141,133,145212,749Dec 11 07:21 PM
APPLE ROBERT FPresident & CEODec 09Sale4.62308,0001,424,4181,905,891Dec 11 07:15 PM
APPLE ROBERT FPresident & CEONov 11Option Exercise1.10100,000110,0001,949,336Nov 13 05:32 PM
GARRITY THOMAS JDirectorNov 01Option Exercise1.1010,00011,000194,186Nov 04 07:01 AM
JACOB LEONARD SDirectorOct 31Option Exercise1.1020,00022,000297,563Nov 04 06:59 AM
GARRITY THOMAS JDirectorMay 01Option Exercise0.5330,00015,900190,213May 03 05:30 PM
GARRITY THOMAS JDirectorMay 01Sale2.6730,00079,968160,213May 03 05:30 PM
JACOB LEONARD SDirectorApr 08Option Exercise0.5392,07848,801331,970Apr 10 05:49 PM
JACOB LEONARD SDirectorApr 08Sale3.0092,078276,243239,892Apr 10 05:49 PM
GONELLA JACQUESDirectorFeb 26Sale3.65200,000730,0009,385,848Feb 28 05:30 PM